𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circulating enterolactone and risk of breast cancer: a prospective study in New York

✍ Scribed by Zeleniuch-Jacquotte, A; Adlercreutz, H; Shore, R E; Koenig, K L; Kato, I; Arslan, A A; Toniolo, P

Book ID
109998104
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
112 KB
Volume
91
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Circulating enterolactone and risk of en
Circulating enterolactone and risk of endometrial cancer
✍ Anne Zeleniuch-Jacquotte; Eva Lundin; Andrea Micheli; Karen L. Koenig; Per Lenne πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 93 KB πŸ‘ 2 views

## Abstract It has been suggested that phytoestrogens protect against hormone‐dependent cancers. Lignans are the main class of phytoestrogens in Western diets. We conducted a prospective study of endometrial cancer and circulating levels of the main human lignan, enterolactone. The design was a cas

Circulating enterolactone and prostate c
Circulating enterolactone and prostate cancer risk: A Nordic nested case-control study
✍ PΓ€r Stattin; Herman Adlercreutz; Leena Tenkanen; Egil Jellum; Sonja Lumme; GΓΆran πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 84 KB πŸ‘ 2 views

## Abstract Enterolactone, a phytoestrogen belonging to the class of lignans, is produced by the intestinal microflora from precursors in plant foods and has been implicated in protection against cancer. We study the effect of enterolactone on the risk of a subsequent diagnosis of prostate cancer.

A prospective study of circulating immun
A prospective study of circulating immune complexes in patients with breast cancer
✍ A. Bukh; M. T. Aguado; N. Krarup; H. S. Poulsen; A. M. Nordentoft; N. P. H. Moll πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 795 KB

Levels of circulating immune complex (clC) and complement split product C3d were studied in 86 patients with breast cancer (BC), 22 patients with benign breast disease (BD), and 72 age-and sex-matched blood-bank donors (NC), using solidphase Clq-protein A RIA, C I q-anti-lgG RIA, anti-C3d anti-lgG R